Delek US Holdings Inc (DK) is not a strong buy for a beginner, long-term investor at this moment. While the company has shown some financial improvements in Q4 2025, its technical indicators suggest the stock is overbought, and analysts have recently lowered price targets. Additionally, options data reflects a bearish sentiment. Given the investor's preference for long-term investments, it would be prudent to wait for a better entry point or more positive catalysts.
The stock is currently overbought with an RSI of 88.304, indicating potential for a near-term pullback. The MACD is positive and expanding, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock closed at $45, nearing the R2 resistance level of $46.925. However, the overbought RSI and proximity to resistance suggest caution.

Q4 2025 financials showed a net profit of $143 million, a significant turnaround from a loss in Q4
Revenue increased by 2% YoY to $2.43 billion.
Adjusted EPS of $2.31 exceeded expectations.
Analysts have recently lowered price targets, with the highest target now at $40, below the current price of $
Gross margin, net income, and EPS have seen significant YoY declines.
The stock is overbought, and technical indicators suggest a potential pullback.
Options data reflects bearish sentiment.
In Q4 2025, Delek US Holdings reported revenue of $2.43 billion, up 2.35% YoY. However, net income dropped by -118.92% YoY to $78.3 million, and EPS fell by -119.88% YoY to $1.3. Gross margin also declined significantly by -253.54% YoY to 9.12. Despite these declines, the company achieved a net profit and exceeded EPS expectations.
Analysts have a neutral to slightly bearish outlook on DK. Recent price target reductions include Morgan Stanley ($38), Citi ($33), Scotiabank ($34), and Piper Sandler ($40). Mizuho is the only firm with an Outperform rating and a higher price target of $51, but this is an outlier. Overall, analysts remain cautious due to valuation concerns and a bearish crude outlook.